Time Left to Bid
No deadline
OpenHealthcare & MedicalFederal
Basic information
- Reference number
- 122343-2026
- Issuing organization
- N/A
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- Suministro de medicamento Axicabtagen Ciloleucel
- Source
- TED (EU)
- Source ID
- 122343-2026
Details
- Location
- ES111, European Union
Summary
Contrato para el suministro sucesivo del medicamento antineoplásico Axicabtagen Ciloleucel para el Área Sanitaria da Coruña e Cee. Contrato directo con Gilead Sciences por derechos exclusivos, con un valor máximo de 71.940.000 EUR.
Contract for successive supply of antineoplastic medication Axicabtagen Ciloleucel for the A Coruña e Cee Health Area. Direct contract with Gilead Sciences due to exclusive rights, with a maximum value of 71,940,000 EUR.
Dates
- Publication
- 2026/02/20 12:00:00 AM UTC
- Closing date
- N/A
Estimated value
$71.9M EUR
How to bid
Classification
Normalized category
Healthcare & Medical